AbCellera Biologics Inc vs ON Holding AG — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while ON Holding AG trades at $31.16 (market cap $10.33B). The key difference: ON Holding AG is far larger — about 3.5× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| ABCL | ONON | |
|---|---|---|
Market Cap | $2.99B | $10.33B |
Sector | Health | Technology |
52-Week High | $9.76 | $50.63 |
52-Week Low | $2.78 | $30.91 |
Enterprise Value | $2.58B | $9.47B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →